Related Experiment Video
Updated: Jun 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Role of statin therapy in stroke prevention
Jason M Morda1, Michael J Ranella, Robert S Rosenson
1Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Insights
Statins effectively lower cholesterol and reduce cardiovascular events. Clinical trials demonstrate that these lipid-lowering drugs significantly decrease stroke incidence, especially in hypertensive individuals.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Serum cholesterol is linked to atherosclerosis.
- Statins (HMG-CoA reductase inhibitors) reduce cardiovascular events.
- Conflicting early data on cholesterol and stroke contrasted with later statin trial findings.
Purpose of the Study:
- To review clinical trial data on lipid lowering for stroke prevention.
- To explore potential mechanisms of statin effects on stroke.
- To focus on trials relevant to hypertensive individuals and stroke subtypes.
Main Methods:
- Systematic review of randomized clinical trials.
- Analysis of data from primary and secondary stroke prevention trials.
- Examination of outcomes stratified by stroke type (hemorrhagic vs. ischemic).
Main Results:
- Randomized trials of statins for coronary heart disease prevention show a reduction in stroke incidence.
- Lipid-lowering therapy demonstrates efficacy in stroke prevention.
- The review highlights specific findings in hypertensive populations.
Conclusions:
- Statins are effective in reducing stroke incidence.
- Lipid lowering represents a viable strategy for stroke prevention.
- Further research is needed to understand differential effects in various patient groups and stroke types.
Abstract:
Serum cholesterol levels have been associated with atherosclerosis and the lowering of serum cholesterol with hydroxy-methyl coenzyme A reductase inhibitors, or statins, has been shown to decrease cardiovascular events. Though early epidemiologic data found conflicting results regarding serum cholesterol levels and stroke, randomized clinical trials of statins for coronary heart disease prevention showed a clear reduction in the incidence of stroke. This review summarizes the clinical trial data surrounding lipid lowering for stroke prevention while also exploring potential mechanisms for such an effect. Particular attention is given to trials for primary and secondary prevention of stroke relevant to the hypertensive individual, and the impact of hemorrhagic vs. ischemic stroke in the outcomes of these trials.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis IV: Nursing Management
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Coronary Artery Disease V: Interprofessional Care